Arcutis Biotherapeutics (ARQT) EBT (2021 - 2025)
Historic EBT for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Q3 2025 value amounting to $7.5 million.
- Arcutis Biotherapeutics' EBT rose 11803.21% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$43.3 million, marking a year-over-year increase of 7781.6%. This contributed to the annual value of -$139.4 million for FY2024, which is 4618.63% up from last year.
- Arcutis Biotherapeutics' EBT amounted to $7.5 million in Q3 2025, which was up 11803.21% from -$15.5 million recorded in Q2 2025.
- In the past 5 years, Arcutis Biotherapeutics' EBT registered a high of $7.5 million during Q3 2025, and its lowest value of -$107.7 million during Q3 2022.
- Over the past 5 years, Arcutis Biotherapeutics' median EBT value was -$52.3 million (recorded in 2024), while the average stood at -$50.0 million.
- Its EBT has fluctuated over the past 5 years, first crashed by 8870.49% in 2022, then skyrocketed by 11803.21% in 2025.
- Quarter analysis of 5 years shows Arcutis Biotherapeutics' EBT stood at -$71.3 million in 2021, then fell by 1.03% to -$72.0 million in 2022, then rose by 8.0% to -$66.3 million in 2023, then skyrocketed by 84.21% to -$10.5 million in 2024, then surged by 171.57% to $7.5 million in 2025.
- Its last three reported values are $7.5 million in Q3 2025, -$15.5 million for Q2 2025, and -$24.8 million during Q1 2025.